Xylazine in Maryland – Initial Report

The Maryland Department of Health’s Overdose Data to Action (OD2A) team recently convened a multiagency workgroup to assess the presence of xylazine in Maryland. The Xylazine in Maryland Workgroup (now the Emerging Drug Trends Workgroup) has released a report of their findings, which includes an examination of post-mortem toxicology data and drug-checking data from Maryland’s Rapid Analysis of Drugs program. The summary of the report provides key takeaways regarding xylazine trends in Maryland. View the summary

You can find the full report here: https://beforeitstoolate.maryland.gov/resources
You can also find general information about xylazine at https://beforeitstoolate.maryland.gov/xylazine

Sorry, comments are closed for this post.